Details of the Drug

General Information of Drug (ID: DMJVFK7)

Drug Name
Meplazumab
Synonyms Mepolizumab
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 1/2 [1]
Therapeutic Class
Antiviral Agents
ATC Code
R03DX09: Meplazumab
R03DX: Other systemic drugs for obstructive airway diseases
R03D: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R: RESPIRATORY SYSTEM
Drug Type
Monoclonal antibody
Cross-matching ID
UNII
0EL07E29VQ
DrugBank ID
DB16465
TTD ID
D03EOF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HUMAN basigin (BSG) TTG21IS BASI_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04275245) Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia. U.S. National Institutes of Health.
2 Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial